GET FREE CONSULTATION!
+256 704 292188
A global campaign named P=P (PrEP = Prevention) has been launched at the International AIDS Society Conference (IAS 2024) in Munich. This initiative aims to advance access to PrEP information and PrEP choices for HIV prevention for all who need it. Charles Brown, Executive Director of Preventive Care International, launched the campaign, calling on global…
Results from two small studies suggest that doxycycline pre-exposure prophylaxis (DoxyPrEP) is a promising strategy for preventing STIs. In recent years, studies have shown that DoxyPEP – taking doxycycline within 72 hours after sex – can prevent bacterial STIs among men who have sex with men and trans women, and evidence suggests that DoxyPEP is…
If global HIV targets are not met, there could be nearly 35 million new HIV acquisitions and nearly 18 million AIDS-related deaths between 2021 and 2050, according to a new analysis. A study, presented by UNAIDS economist Erik Lamontagne, estimates the human and economic cost of failing to meet “95-95-95” targets in 114 countries. These…
A unique HIV cure case is among the scientific highlights of AIDS 2024, the 25th International AIDS Conference, taking place in Munich, Germany and virtually from 22 to 26 July. Scientists shared information about the “next Berlin Patient,” who appears to be the world’s seventh person cured of HIV following a stem cell transplant. This…